ABT (STOCKS)
Abbott Laboratories
$111.170000
+0.260000 (+0.23%)
Prev close: $110.910000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Robert B. Ford
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $199,369.89M
- Employees
- 114,000
- P/E (TTM)
- 35.85
- P/B (TTM)
- 3.75
- Dividend Yield
- 223.60%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
11
Strong Buy
13
Buy
9
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$1.31 | $1.29 | +0.0178 | +1.38% |
|
Mar 2026 (Q1)
|
$1.15 | $1.16 | -0.0052 | -0.45% |
|
Dec 2025 (Q4)
|
$1.50 | $1.51 | -0.0113 | -0.75% |
|
Sep 2025 (Q3)
|
$1.30 | $1.31 | -0.0139 | -1.06% |
Financial Statements
| Revenues | $46.59B |
| Benefits Costs and Expenses | $39.07B |
| Cost Of Revenue | $20.21B |
| Costs And Expenses | $39.24B |
| Gross Profit | $26.37B |
| Operating Expenses | $19.03B |
| Selling, General, and Administrative Expenses | $13.95B |
| Research and Development | $3.16B |
| Other Operating Expenses | $1.92B |
| Operating Income/Loss | $7.35B |
| Income/Loss From Continuing Operations After Tax | $5.43B |
| Income/Loss From Continuing Operations Before Tax | $7.51B |
| Income Tax Expense/Benefit | $2.09B |
| Net Income/Loss | $5.43B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $5.43B |
| Net Income/Loss Available To Common Stockholders, Basic | $5.40B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $25.00M |
| Preferred Stock Dividends And Other Adjustments | $25.00M |
| Basic Earnings Per Share | $3.10 |
| Diluted Earnings Per Share | $3.09 |
| Basic Average Shares | 1,741,090,000 |
| Diluted Average Shares | 1,743,960,000 |
| Assets | $109.22B |
| Current Assets | $24.52B |
| Inventory | $7.32B |
| Other Current Assets | $17.20B |
| Noncurrent Assets | $84.70B |
| Fixed Assets | $12.81B |
| Intangible Assets | $17.21B |
| Other Non-current Assets | $54.68B |
| Liabilities | $57.45B |
| Current Liabilities | $17.81B |
| Wages | $1.62B |
| Other Current Liabilities | $16.20B |
| Noncurrent Liabilities | $39.64B |
| Equity | $51.76B |
| Equity Attributable To Noncontrolling Interest | $652.00M |
| Equity Attributable To Parent | $51.11B |
| Liabilities And Equity | $109.22B |
| Net Cash Flow From Operating Activities | $9.91B |
| Net Cash Flow From Operating Activities, Continuing | $9.91B |
| Net Cash Flow From Investing Activities | -$22.37B |
| Net Cash Flow From Investing Activities, Continuing | -$22.37B |
| Net Cash Flow From Financing Activities | $10.64B |
| Net Cash Flow From Financing Activities, Continuing | $10.64B |
| Net Cash Flow | -$1.82B |
| Net Cash Flow, Continuing | -$1.82B |
| Comprehensive Income/Loss | $5.79B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $5.79B |
| Other Comprehensive Income/Loss | $5.79B |
| Other Comprehensive Income/Loss Attributable To Parent | $364.00M |